Ki67 expression at Kasai portoenterostomy as a prognostic factor in patients with biliary atresia

Abstract

Background: Biliary atresia is a rare paediatric biliary obliteration disease with unknown aetiology, and is the most common indication for paediatric liver transplantation (LT). However, no consensus for predicting Kasai portoenterostomy (KP) outcomes using liver histological findings exists. Ki67 is a popular biomarker for measuring and monitoring cellular proliferation. Methods: Ki67 (clone, MIB-1) liver parenchyma expression was measured by immunohistochemical staining of samples from living donors and patients with biliary atresia to assess its value in predicting outcomes after KP. Results: Of 35 children with biliary atresia, 13 were native liver survivors (NLS), 17 were non-NLS, and five had primary LT. The median proportion of Ki67 immunostained areas in donors and patients with biliary atresia at KP was 0⋅06 and 0⋅99 per cent respectively. Univariable analysis identified a high proportion of Ki67 areas, high Ki67 cell numbers and high Ki67-positive/leucocyte common antigen-positive cell numbers at KP as significant predictors of poor native liver survival after KP (hazard ratio 9⋅29, 3⋅37 and 12⋅17 respectively). The proportion of Ki67 areas in the non-NLS group was significantly higher than that in the NLS group (1⋅29 versus 0⋅72 per cent respectively; P = 0⋅001), and then decreased at LT (0⋅32 per cent versus 1⋅29 per cent at KP; P < 0⋅001). Conclusion: This study has demonstrated the clinical data and time course of Ki67 expression in patients with biliary atresia. High Ki67 expression at KP may be an important predictor of native liver survival following the procedure.

The Prognostic Value of Serum Albumin to Globulin Ratio in Patients with Breast Cancer: A Retrospective Study

“… 11 Ki67 has long been favored as a biomarker for assessing tumor proliferation, especially in BC. 12 In addition, the combination of pretreatment plasma HSP90AA1 with other markers provides a convenient method for predicting the risk of BC development and metastasis. 13 Cathepsin D was proposed as a tumor marker in human BC many years ago.…”